标题
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2022-05-27
DOI
10.1021/acs.jmedchem.2c00303
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis
- (2022) Daniele Focosi et al. ANTIVIRAL RESEARCH
- Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease
- (2022) Lennart Brewitz et al. ChemMedChem
- Design and Evaluation of a Novel Peptide–Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease
- (2022) Na Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
- (2022) Laura A. VanBlargan et al. NATURE MEDICINE
- Lethal mutagenesis as an antiviral strategy
- (2022) Ronald Swanstrom et al. SCIENCE
- Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
- (2022) Devin S. M. Lewis et al. Scientific Reports
- A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection
- (2022) Pehuén Pereyra Gerber et al. PLoS Pathogens
- Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay
- (2022) Wenyue Cao et al. ACS Central Science
- Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
- (2022) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants
- (2022) Samantha E. Greasley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
- (2022) Laura J. Stevens et al. Science Translational Medicine
- Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond
- (2021) Ashley N. Matthew et al. CHEMICAL REVIEWS
- Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors
- (2021) Jonathan M. O. Rawson et al. Viruses-Basel
- The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
- (2021) Ziyang Fu et al. Nature Communications
- Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2
- (2021) Wendy P. Painter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
- (2021) Chunlong Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
- (2021) Jerzy Osipiuk et al. Nature Communications
- Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
- (2021) Ewelina Weglarz-Tomczak et al. Scientific Reports
- Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro
- (2021) Chuan Xu et al. Pathogens
- β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
- (2021) Shuntai Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
- (2021) Yao Zhao et al. Protein & Cell
- A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
- (2021) Yingzhu Li et al. ACS Central Science
- Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
- (2021) Chew Theng Lim et al. BIOCHEMICAL JOURNAL
- Drug Repurposing for the SARS‐CoV‐2 Papain‐Like Protease
- (2021) Wenshe Liu et al. ChemMedChem
- Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
- (2021) Veronica Di Sarno et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
- (2021) Florian Kabinger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
- (2021) Kangsa Amporndanai et al. Nature Communications
- In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
- (2021) Agnieszka M. Szemiel et al. PLoS Pathogens
- Ethacridine inhibits SARS-CoV-2 by inactivating viral particles
- (2021) Xiaoquan Li et al. PLoS Pathogens
- Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
- (2021) Chunlong Ma et al. ACS Central Science
- The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus
- (2021) Zhen Qiao et al. BIOORGANIC CHEMISTRY
- Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease
- (2021) Yunxia Xu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
- (2021) Zhengnan Shen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity
- (2021) Chunlong Ma et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
- (2021) Joseph Heskin et al. LANCET
- Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection
- (2021) Deeksha Munnur et al. NATURE IMMUNOLOGY
- ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection
- (2021) Xuetao Cao NATURE IMMUNOLOGY
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
- (2021) Chunlong Ma et al. Acta Pharmaceutica Sinica B
- 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
- (2021) Caleb D. Swaim et al. iScience
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease
- (2020) Brendan T Freitas et al. ACS Infectious Diseases
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Virucidal efficacy of different oral rinses against SARS-CoV-2
- (2020) Toni Luise Meister et al. JOURNAL OF INFECTIOUS DISEASES
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
- (2020) Theresa Klemm et al. EMBO JOURNAL
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CLpro Reporter Assay
- (2020) Heather M. Froggatt et al. JOURNAL OF VIROLOGY
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
- (2020) Wioletta Rut et al. Science Advances
- Crystal structure of SARS-CoV-2 papain-like protease
- (2020) Xiaopan Gao et al. Acta Pharmaceutica Sinica B
- Protease inhibitors targeting the main protease and papain-like protease of coronaviruses
- (2020) Clemente Capasso et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2
- (2020) Felix Pahmeier et al. JOURNAL OF VIROLOGY
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
- (2020) Robert M. Cox et al. Nature Microbiology
- Designing a Green Fluorogenic Protease Reporter by Flipping a Beta Strand of GFP for Imaging Apoptosis in Animals
- (2019) Qiang Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
- (2018) Jian Lei et al. ANTIVIRAL RESEARCH
- MERS-CoV: Understanding the Latest Human Coronavirus Threat
- (2018) et al. Viruses-Basel
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- How to Triage PAINS-Full Research
- (2016) Jayme L. Dahlin et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease
- (2016) Miklós Békés et al. MOLECULAR CELL
- Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
- (2015) Hyun Lee et al. ACS Chemical Biology
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
- (2015) Kai-Wen Cheng et al. ANTIVIRAL RESEARCH
- PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
- (2015) Jayme L. Dahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
- (2014) Yahira M. Báez-Santos et al. JOURNAL OF MEDICINAL CHEMISTRY
- MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
- (2013) Anna M. Mielech et al. VIROLOGY
- Profiling the NIH Small Molecule Repository for Compounds That Generate H2O2 by Redox Cycling in Reducing Environments
- (2010) Karina M. Soares et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents—real hits or promiscuous artifacts?
- (2010) Paul A Johnston CURRENT OPINION IN CHEMICAL BIOLOGY
- Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method
- (2010) E. R. Gaunt et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation
- (2010) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coronavirus Genomics and Bioinformatics Analysis
- (2010) Patrick C. Y. Woo et al. Viruses-Basel
- Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease
- (2009) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
- (2008) Chi-Yuan Chou et al. BIOCHEMICAL PHARMACOLOGY
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
- (2008) K. Ratia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now